Similar articles

• Ticlopidine monotherapy following coronary stent deployment: "penny wise and pound foolish".

  Kereiakes DJ, Young JJ, Runyon JP, Shimshak TM. Kereiakes DJ, et al. J Invasive Cardiol. 2001 Jun;13(6):437-8. J Invasive Cardiol. 2001. PMID: 11385164 No abstract available.
• Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.

  Yan BP, Gurvitch R, Ajani AE. Yan BP, et al. Cardiovasc Revasc Med. 2006 Jul-Sep;7(3):155-8. doi: 10.1016/j.carrev.2006.04.001. Cardiovasc Revasc Med. 2006. PMID: 16945822 Review.
• Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting.

  Goods CM, al-Shaibi KF, Liu MW, Yadav JS, Mathur A, Jain SP, Dean LS, Iyer SS, Parks JM, Roubin GS. Goods CM, et al. Am J Cardiol. 1996 Nov 1;78(9):1042-4. doi: 10.1016/s0002-9149(96)00532-2. Am J Cardiol. 1996. PMID: 8916486
• Ticlopidine and aspirin therapy following implantation of coronary artery stents.

  Hobson AG, Sowinski KM. Hobson AG, et al. Ann Pharmacother. 1997 Jun;31(6):770-2. Ann Pharmacother. 1997. PMID: 9184720 Review.
• Antithrombotic therapy with intracoronary stenting.

  Steinhubl SR, Lincoff AM. Steinhubl SR, et al. Heart. 1997 Oct;78 Suppl 2(Suppl 2):21-3. doi: 10.1136/hrt.78.suppl_2.21. Heart. 1997. PMID: 9422970 Free PMC article. No abstract available.